- Home
- PLTK vs NBTX Comparison
PLTK vs NBTX Comparison
Compare PLTK & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLTK | NBTX |
|---|---|---|
| Founded | 2010 | 2003 |
| Country | Israel | France |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | PLTK | NBTX |
|---|---|---|
| Price | $3.14 | $29.90 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $5.04 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 1.5M | 45.1K |
| Earning Date | 05-07-2026 | 03-31-2026 |
| Dividend Yield | ★ 12.74% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,755,400,000.00 | N/A |
| Revenue This Year | $2.60 | $60.67 |
| Revenue Next Year | $2.23 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.08 | N/A |
| 52 Week Low | $2.64 | $3.12 |
| 52 Week High | $5.59 | $41.89 |
Technical Indicators
Market Signals| Indicator | PLTK | NBTX |
|---|---|---|
| Relative Strength Index (RSI) | 56.62 | 48.55 |
| Support Level | N/A | $28.40 |
| Resistance Level | $3.82 | $30.23 |
| Average True Range (ATR) | 0.13 | 1.73 |
| MACD | 0.05 | -0.29 |
| Stochastic Oscillator | 84.35 | 27.08 |
Price Performance
Historical ComparisonAbout PLTK Playtika Holding Corp.
Playtika Holding Corp is engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC, and Other regions of which key revenue is derived from the USA. The company offers both Mobile and Web-based platforms.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.